Post-approval studies (Phase 4)Study completedNCT01158599
What this trial is testing
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population
Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 200